AI and PET/MRI join forces to decode tumor aggressiveness
NCT ID NCT04687969
First seen Sep 30, 2025 · Last updated May 22, 2026 · Updated 28 times
Summary
This study tested whether combining PET/MRI scans with machine learning can more accurately determine how aggressive solid tumors like prostate cancer are. Researchers scanned 50 adults with prostate, liver, kidney, or brain tumors and compared the AI results to standard tissue analysis. The goal was to improve diagnosis, not to provide a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.